Direct-to-consumer advertising increases statin use and high cholesterol diagnosis

Monday, March 25, 2013 by: Katie BrindAmour
Tags: DTC advertising, statin drugs, cholesterol

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
CDC issues flu vaccine apology: this year's vaccine doesn't work!
The five biggest lies about Ebola being pushed by government and mass media
Ultraviolet light robot kills Ebola in two minutes; why doesn't every hospital have one of these?
Tetanus vaccines found spiked with sterilization chemical to carry out race-based genocide against Africans
Biologist explains how marijuana causes tumor cells to commit suicide
Companies begin planting microchips under employees' skin
The best way to help your body protect itself against Ebola (or any virus or bacteria)
NJ cops bust teenagers shoveling snow without a permit
Russia throws down the gauntlet: energy supply to Europe cut off; petrodollar abandoned as currency war escalates
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
W.H.O. contradicts CDC, admits Ebola can spread via coughing, sneezing and by touching contaminated surfaces
Top ten things you need to do NOW to protect yourself from an uncontrolled Ebola outbreak
Chemotherapy kills cancer patients faster than no treatment at all
FDA targets Dr. Bronner's Magic Soaps for sharing health benefits of coconut oil
U2's Bono partners with Monsanto to destroy African agriculture with GMOs
Why flu shots are the greatest medical fraud in history
Governments seize colloidal silver being used to treat Ebola patients, says advocate
Flu vaccine kills 13 in Italy; death toll rises

(NaturalNews) Skeptics of the pharmaceutical industry have long expressed concern over the effect of direct-to-consumer advertising on diagnosis rates and prescription drug use. Perhaps not surprisingly, researchers at Cornell University recently found that exposure to advertisements about statins increased viewers' likelihood of being diagnosed and of using statins by 16-22 percent for both men and women. Most interestingly; however, the study found that this effect only held for people who were in least need of pharmaceutical treatment: the group of women and men at low risk of a future cardiac event.

The researchers point out that, for the low-risk group most affected by direct-to-consumer ads, the side effects or drawbacks of taking statins may outweigh the detrimental impact of untreated high cholesterol. High-risk women in the study were actually significantly less likely than those in moderate or low-risk categories to seek out statins despite exposure to direct advertising.

Self-diagnosis and the digital world of health information

With today's bounty of medical information online, individuals could simply run their symptoms through a symptom search to begin self-diagnosing or self-referring to cardiac specialists for problems such as high cholesterol. Although self-diagnosis has its perks - like motivating patients to seek professional medical advice and encouraging them to adhere to treatment regimens - it also can get in the way of more practical and less invasive medicine (like diet and exercise recommendations).

As the FDA looks into expanding over-the-counter access to a variety of drugs (including those for high cholesterol and high blood pressure), accurate self-diagnosis that still draws simple lifestyle-based advice will become especially crucial.

About one in three American adults has high cholesterol, and fewer than half of them get treatment for their condition. The list of complaints and supports for direct-to-consumer advertising for pharmaceuticals is lengthy and has strong arguments on both sides. The FDA has made multiple attempts to curb certain aspects of this advertisement industry, each time with different levels of success. Additional restrictions often requested include limits on the ability to mention specific drug names or the types of efficacy claims an ad can make.

Although a comprehensive reform is unlikely in the near future, one thing remains certain: direct-to-consumer advertising for prescription drugs significantly impacts the map of diagnoses and drug use in the United States, for better or worse.

Sources for this article include:

About the author:
Katie BrindAmour is a Certified Health Education Specialist and passionate health and wellness freelance writer. She enjoys cooking, yoga, gardening, searching for the perfect wine and chocolate combination, and spending time with friends. She has a Masters in Biology and is currently pursuing her PhD in Health Services Management and Policy. She also enjoys blogging for Women's Healthcare Topics and Healthline Networks.

Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...


Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of, the internet's No. 1 natural health news site. (Source:

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.